Big Pharma aren't looking at molecules that target protein vpu yet...
So I think Biotron could be leading the race there.
Bitoron have thought of BIT225 as a late-acting drug, but form the above article it appears Vpu inhibitors might play a more primary role in he initial stage of an HIV infection.
achilles heel, page-4
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.26M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312047 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 42000 | 1 |
View Market Depth
| Last trade - 11.07am 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable